TOP2A and neoplasm: Another proposed mechanism for the cardiotoxicity of anthracyclines is its intended anti-tumor mechanism of DNA–topioisomerase2 (Top2) intercalation, wherein the anthracycline forms a Top2–doxorubicin–DNA ternary complex.